Statins could reduce COVID-19 severity and hospital stays, study finds

The research study group discovered that taking statins before hospitalization decreased COVID-19 clients danger of developing a severe case of the disease by more than 50 percent, as well as led to faster recovery times.

Katie Adams –
Friday, September 25th, 2020
Print|Email.

A 2nd UC San Diego research group on Sept. 18 released a mechanistic study in The EMBO Journal describing that statins possible to minimize the threat of serious COVID-19 comes from the drug classs capability to eliminate cholesterol from cell membranes, which avoids the unique coronavirus from getting in.

More articles on pharmacy: FDA now needing boxed warning for benzodiazepinesAlbertsons names previous Amazon exec as new head of pharmacyCuomo to form review council for COVID-19 vaccines, states hes cautious of approval process politicization.

Statins, a class of commonly-prescribed cholesterol-lowering drugs, could reduce clients risk of establishing severe COVID-19, according to research study recently published in the American Journal of Cardiology.

University of California San Diego researchers published a medical study Sept. 15 in which they took a look at the medical records of 170 COVID-19 patients and 5,281 control patients without the illness who were hospitalized at UC San Diego Health between February and June. They examined the anonymized information to much better understand the relationship in between making use of statins prior to hospitalization and period of healthcare facility stay, illness seriousness and outcome.

Albertsons names previous Amazon officer as new head of pharmacy.

© Copyright ASC COMMUNICATIONS 2020. Intrigued in LINKING to or REPRINTING this material? View our policies by click on this link.